| GFI group (n = 24) | Non-GFI group (n = 69) | P |
---|---|---|---|
Age | 40 (33–48) | 40 (33–48) | 0.954 |
Male | 13 (54.2) | 50 (72.5) | 0.099 |
BMI | 26.2 (23.6–28.4) | 26.1 (24.1–30.1) | 0.706 |
APACHE II | 10 (7–11) | 7 (5–10) | 0.003 |
Time from onset of abdominal pain to study hospital admission | 4 (1–4) | 3 (2–5) | 0.771 |
RAC |  |  |  < 0.001 |
 Moderate | 8 (33.3) | 60 (87) |  |
 Severe | 16 (66.7) | 9 (13) |  |
Etiology | Â | Â | 0.565 |
 Hypertriglyceridemia | 12 (50) | 31 (44.9) |  |
 Biliary | 10 (41.7) | 26 (37.7) |  |
 Others | 2 (8.3) | 12 (17.4) |  |
Systemic complications at hospital admission | Â | Â | Â |
 Respiratory failure | 16 (66.7) | 23 (33.3) | 0.004 |
 AKI | 5 (20.8) | 2 (2.9) | 0.016 |
 Shock | 2 (8.3) | 1 (1.4) | 0.162 |
Clinical outcomes | Â | Â | Â |
 Energy target-reaching rate between day3-day7 | 12 (50) | 61 (88.4) |  < 0.001 |
 Hospital mortality | 1 (4.2) | 0 (0) | 0.258 |
 Length of hospital stay, day | 18 (9–31) | 6 (4–9) |  < 0.001 |
 Pancreaticocutaneous fistula | 1 (4.2) | 0 (0) | 0.258 |
 Abdominal bleeding | 2 (8.3) | 0 (0) | 0.065 |
 IPN | 3 (12.5) | 0 (0) | 0.016 |
New receipt of organ support therapy | Â | Â | Â |
 MV | 2 (8.3) | 1 (1.4) | 0.162 |
 Vasopressors | 1 (4.2) | 0 (0) | 0.258 |
Mean total inpatient hospital costs, k¥ | 88.2 (42.2–16.2) | 29.4 (22.3–42.0) |  < 0.001 |